These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
170 related articles for article (PubMed ID: 11787530)
21. [The clinical evaluation of preemptive treatment of cytomegalovirus infection after allogeneic hematopoietic stem cell transplantation]. Zhang P; Wang C; Jiang JL; Jiang Y; Yan SK; Yang J Zhonghua Nei Ke Za Zhi; 2009 Jul; 48(7):539-41. PubMed ID: 19957791 [TBL] [Abstract][Full Text] [Related]
22. Risk factors for late cytomegalovirus infection after allogeneic stem cell transplantation using HLA-matched sibling donor: donor lymphocyte infusion and previous history of early CMV infection. Kim DH; Kim JG; Lee NY; Sung WJ; Sohn SK; Suh JS; Lee KS; Lee KB Bone Marrow Transplant; 2004 Jul; 34(1):21-7. PubMed ID: 15133483 [TBL] [Abstract][Full Text] [Related]
23. Hemorrhagic cystitis following hematopoietic stem cell transplantation: incidence, risk factors and association with CMV reactivation and graft-versus-host disease. Xu LP; Zhang HY; Huang XJ; Liu KY; Liu DH; Han W; Chen H; Chen YH; Gao ZY; Zhang YC; Lu DP Chin Med J (Engl); 2007 Oct; 120(19):1666-71. PubMed ID: 17935666 [TBL] [Abstract][Full Text] [Related]
24. Study on the colonoscopic features of GVHD enteritis that developed after hematopoietic stem cell transplantation. Harada K; Higaki S; Hashimoto K; Hashimoto S; Oga A; Gondo T; Sakaida I Hepatogastroenterology; 2007 Dec; 54(80):2221-7. PubMed ID: 18265637 [TBL] [Abstract][Full Text] [Related]
25. Cytomegalovirus (CMV) infections in children undergoing hematopoetic stem cell transplantation. Zaucha-Prazmo A; Wójcik B; Drabko K; Choma M; Kowalczyk JR Pediatr Hematol Oncol; 2005 Jun; 22(4):271-6. PubMed ID: 16020113 [TBL] [Abstract][Full Text] [Related]
26. Monitoring of cytomegalovirus reactivation after allogeneic stem cell transplantation: comparison of an antigenemia assay and quantitative real-time polymerase chain reaction. Yakushiji K; Gondo H; Kamezaki K; Shigematsu K; Hayashi S; Kuroiwa M; Taniguchi S; Ohno Y; Takase K; Numata A; Aoki K; Kato K; Nagafuji K; Shimoda K; Okamura T; Kinukawa N; Kasuga N; Sata M; Harada M Bone Marrow Transplant; 2002 Apr; 29(7):599-606. PubMed ID: 11979310 [TBL] [Abstract][Full Text] [Related]
27. Risk factors for the development of cytomegalovirus disease after allogeneic stem cell transplantation. Ljungman P; Perez-Bercoff L; Jonsson J; Avetisyan G; Sparrelid E; Aschan J; Barkholt L; Larsson K; Winiarski J; Yun Z; Ringdén O Haematologica; 2006 Jan; 91(1):78-83. PubMed ID: 16434374 [TBL] [Abstract][Full Text] [Related]
28. Detection of human cytomegalovirus (CMV) DNA in feces has limited value in predicting CMV enteritis in patients with intestinal graft-versus-host disease after allogeneic stem cell transplantation. Sun YQ; Xu LP; Han TT; Zhang XH; Wang Y; Han W; Wang FR; Wang JZ; Chen H; Chen YH; Yan CH; Chen Y; Liu KY; Huang XJ Transpl Infect Dis; 2015 Oct; 17(5):655-61. PubMed ID: 26275161 [TBL] [Abstract][Full Text] [Related]
30. [Quantitative monitoring of blood cytomegalovirus after allogeneic hematopoietic stem cell transplantation and its clinical significance]. Qiu ZX; Wang MJ; Wang LH; Sun YH; Xu WL; Liu W; Ou JP; Dong YJ; Li Y; Liang ZY; Cen XN; Ren HY Zhonghua Nei Ke Za Zhi; 2012 May; 51(5):371-5. PubMed ID: 22883336 [TBL] [Abstract][Full Text] [Related]
31. Interferon gamma 13-CA-repeat homozygous genotype and a low proportion of CD4(+) lymphocytes are independent risk factors for cytomegalovirus reactivation with a high number of copies in hematopoietic stem cell transplantation recipients. Jaskula E; Dlubek D; Duda D; Bogunia-Kubik K; Mlynarczewska A; Lange A Biol Blood Marrow Transplant; 2009 Oct; 15(10):1296-305. PubMed ID: 19747638 [TBL] [Abstract][Full Text] [Related]
32. Cytomegalovirus antigenemia and outcome of patients treated with pre-emptive ganciclovir: retrospective analysis of 241 consecutive patients undergoing allogeneic hematopoietic stem cell transplantation. Yanada M; Yamamoto K; Emi N; Naoe T; Suzuki R; Taji H; Iida H; Shimokawa T; Kohno A; Mizuta S; Maruyama F; Wakita A; Kitaori K; Yano K; Hamaguchi M; Hamajima N; Morishima Y; Kodera Y; Sao H; Morishita Y Bone Marrow Transplant; 2003 Oct; 32(8):801-7. PubMed ID: 14520425 [TBL] [Abstract][Full Text] [Related]
33. Suspected delayed immune recovery against cytomegalovirus after reduced-intensity stem cell transplantation using anti-thymocyte globulin. Nakai K; Kanda Y; Mineishi S; Saito T; Ohnishi M; Niiya H; Chizuka A; Takeuchi T; Matsubara H; Kami M; Makimoto A; Tanosaki R; Kunitoh H; Tobinai K; Takaue Y Bone Marrow Transplant; 2002 Feb; 29(3):237-41. PubMed ID: 11859396 [TBL] [Abstract][Full Text] [Related]
34. Clinical significance of serum hepcidin levels on early infectious complications in allogeneic hematopoietic stem cell transplantation. Kanda J; Mizumoto C; Kawabata H; Ichinohe T; Tsuchida H; Tomosugi N; Matsuo K; Yamashita K; Kondo T; Ishikawa T; Uchiyama T Biol Blood Marrow Transplant; 2009 Aug; 15(8):956-62. PubMed ID: 19589485 [TBL] [Abstract][Full Text] [Related]
35. Frequent occurrence of cytomegalovirus retinitis during immune reconstitution warrants regular ophthalmic screening in high-risk pediatric allogeneic hematopoietic stem cell transplant recipients. Hiwarkar P; Gajdosova E; Qasim W; Worth A; Breuer J; Chiesa R; Ridout D; Edelsten C; Moore A; Amrolia P; Veys P; Rao K Clin Infect Dis; 2014 Jun; 58(12):1700-6. PubMed ID: 24700657 [TBL] [Abstract][Full Text] [Related]
36. Cytomegalovirus infections following umbilical cord blood transplantation using reduced intensity conditioning regimens for adult patients. Matsumura T; Narimatsu H; Kami M; Yuji K; Kusumi E; Hori A; Murashige N; Tanaka Y; Masuoka K; Wake A; Miyakoshi S; Kanda Y; Taniguchi S Biol Blood Marrow Transplant; 2007 May; 13(5):577-83. PubMed ID: 17448917 [TBL] [Abstract][Full Text] [Related]
37. Persisting posttransplantation cytomegalovirus antigenemia correlates with poor lymphocyte proliferation to cytomegalovirus antigen and predicts for increased late relapse and treatment failure. Nakamura R; Battiwalla M; Solomon S; Follmann D; Chakrabarti S; Cortez K; Hensel N; Childs R; Barrett AJ Biol Blood Marrow Transplant; 2004 Jan; 10(1):49-57. PubMed ID: 14752779 [TBL] [Abstract][Full Text] [Related]
38. Rising antigenemia levels may be misleading in pre-emptive therapy of human cytomegalovirus infection in allogeneic hematopoietic stem cell transplant recipients. Gerna G; Lilleri D; Zecca M; Alessandrino EP; Baldanti F; Revello MG; Locatelli F Haematologica; 2005 Apr; 90(4):526-33. PubMed ID: 15820949 [TBL] [Abstract][Full Text] [Related]
39. [Risk factors of cytomegalovirus infection and antiviral efficacy in recipients of hematopoietic stem cell transplantation]. Ding H; Ren H; Guo N; Huang X; Xu L; Zhang Y; Lu D Beijing Da Xue Xue Bao Yi Xue Ban; 2003 Dec; 35(6):596-9. PubMed ID: 14710251 [TBL] [Abstract][Full Text] [Related]
40. Clinical features and outcomes of cytomegalovirus retinitis after transplantation. Eid AJ; Bakri SJ; Kijpittayarit S; Razonable RR Transpl Infect Dis; 2008 Feb; 10(1):13-8. PubMed ID: 17511815 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]